home All News open_in_new Full Article

Hidden factor in cancer treatment timing may affect survival, researchers say

Timing matters: Lung cancer patients receiving immunochemotherapy earlier in the day had a 52% lower risk of progression in a new medical study.


today 4 w. ago attach_file Events

attach_file Politics
attach_file Events
attach_file Politics
attach_file Events
attach_file Events
attach_file Events
attach_file Events
attach_file Events
attach_file Politics
attach_file Science
attach_file Events
attach_file Politics


ID: 2959535894
Add Watch Country

arrow_drop_down